537 related articles for article (PubMed ID: 21193545)
41. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study.
Vagi SJ; Azziz-Baumgartner E; Sjödin A; Calafat AM; Dumesic D; Gonzalez L; Kato K; Silva MJ; Ye X; Azziz R
BMC Endocr Disord; 2014 Oct; 14():86. PubMed ID: 25348326
[TBL] [Abstract][Full Text] [Related]
42. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
43. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
44. Maternal and fetal exposure to bisphenol A in Korea.
Lee YJ; Ryu HY; Kim HK; Min CS; Lee JH; Kim E; Nam BH; Park JH; Jung JY; Jang DD; Park EY; Lee KH; Ma JY; Won HS; Im MW; Leem JH; Hong YC; Yoon HS
Reprod Toxicol; 2008 Aug; 25(4):413-9. PubMed ID: 18577445
[TBL] [Abstract][Full Text] [Related]
45. Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary Syndrome.
Belan M; Pelletier C; Baillargeon JP
Metab Syndr Relat Disord; 2017 Apr; 15(3):145-152. PubMed ID: 28339345
[TBL] [Abstract][Full Text] [Related]
46. A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity?
Alanbay I; Ercan CM; Sakinci M; Coksuer H; Ozturk M; Tapan S
Arch Gynecol Obstet; 2012 Oct; 286(4):1065-71. PubMed ID: 22718099
[TBL] [Abstract][Full Text] [Related]
47. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
48. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.
Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417
[TBL] [Abstract][Full Text] [Related]
49. Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index.
Sharifi F; Hajihosseini R; Mazloomi S; Amirmogaddami H; Nazem H
Metab Syndr Relat Disord; 2010 Feb; 8(1):47-52. PubMed ID: 19929617
[TBL] [Abstract][Full Text] [Related]
50. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
51. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
52. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome.
Akgül S; Sur Ü; Düzçeker Y; Balcı A; Kızılkan MP; Kanbur N; Bozdağ G; Erkekoğlu P; Gümüş E; Kocer-Gumusel B; Derman O
Gynecol Endocrinol; 2019 Dec; 35(12):1084-1087. PubMed ID: 31219355
[TBL] [Abstract][Full Text] [Related]
53. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
54. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
[TBL] [Abstract][Full Text] [Related]
55. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
56. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
57. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
Yasmin E; Balen AH; Barth JH
Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
[TBL] [Abstract][Full Text] [Related]
58. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
59. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
60. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
